Cancer-associated IDH mutations generate the oncometabolite, D-2-hydroxyglutarate, a competitive suppressor of α-ketoglutarate-dependent dioxygenases, and lock IDH-mutant cancer cells in a stem-like state 195-197. The gene discussed is IDH2; the disease is cancer.